Advantex Announces Fiscal 2025 Financial Results

Executive Summary

• Advantex reported a 33% revenue increase to $4.24 M and a 156% jump in EBITDA to $1.31 M for fiscal year ended June 30, 2025.
• Gross margins improved markedly (MCA program margin up to 93%; Aeroplan program margin up to 45%).
• The company secured a new Receivables Purchase Agreement to sell up to $20 M of MCA receivables, expanding non‑dilutive funding capacity.

Key Details

• Revenue: $4.24 M (↑33% YoY from $3.18 M).
• Gross Profit: $3.02 M (↑39%).
• Gross Margins: MCA program 93% (up from 82%); Aeroplan program 45% (up from 33%).
• EBITDA: $1.31 M (↑156% YoY; prior $0.51 M).
• Net Loss: $2.63 M (narrowed 3% vs. $2.70 M in FY2024).
• G&A Expenses: $1.22 M (up from $1.11 M).
• MCA Portfolio Growth: Transaction credits rose 54% to $7.87 M (vs. $5.10 M YoY).
• Aeroplan Program: Revenue more than doubled year‑over‑year following five‑year renewal through Aug 2028.
• Debt Management: Holders of 9% non‑convertible debentures deferred interest payments and reset covenants; company remained in compliance at year‑end.
• Credit Facility: Automatic one‑year renewal in July 2025, funding 90% of MCA transaction credits.
• New Funding Partnership: October 2025 Receivables Purchase Agreement to originate/sell up to $20 M of MCA receivables – non‑dilutive growth platform.
• Outlook FY2026: Anticipates increased demand for MCA products amid economic uncertainty; expects expanded origination capacity with new funding partner while maintaining prudent credit standards.

Notable Quotes

“Fiscal 2025 demonstrated the resilience of our business model,” said Kelly Ambrose, President and CEO. “We have strengthened our core MCA portfolio, deepened our relationships with existing and new funding partners, and positioned Advantex to scale efficiently in the year ahead.”